pyrazines has been researched along with androstenedione in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ohmori, K; Ohta, A; Sugawara, S; Yamada, K | 1 |
Brandalise, SR; Cardinalli, I; de Castro, M; Fedatto, PF; Leal, LF; Marco Antonio, DS; Martinelli, CE; Mastellaro, MJ; Neder, L; Peixoto Lira, RC; Ramalho, L; Rauber Antonini, SR; Scrideli, CA; Seidinger, AL; Tone, LG; Tucci, S; Yunes, JA | 1 |
2 other study(ies) available for pyrazines and androstenedione
Article | Year |
---|---|
Effect of 3,6-dimethylpyrazine-2-thiol on androstenedione-induced increase of uterine weight in female rats.
Topics: Aminoglutethimide; Androstenedione; Animals; Aromatase; Aromatase Inhibitors; Drug Interactions; Enzyme Inhibitors; Female; Organ Size; Pregnancy; Pyrazines; Rats; Rats, Wistar; Testosterone; Uterus | 1999 |
IGF2 and IGF1R in pediatric adrenocortical tumors: roles in metastasis and steroidogenesis.
Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Androgens; Androstenedione; Apoptosis; Cell Line, Tumor; Child; Child, Preschool; Dehydroepiandrosterone Sulfate; Female; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Infant; Insulin-Like Growth Factor II; Male; Neoplasm Recurrence, Local; Phosphoproteins; Pyrazines; Receptor, IGF Type 1; Receptors, Somatomedin; RNA, Messenger; Testosterone | 2016 |